Ipsen UK

The UK & Ireland together form one of three global hubs for Ipsen, encompassing the entire value chain of medicines discovery, development, manufacturing and commercialisation.Ipsen was first established as a business in the UK in 1981, and in Ireland in 1989. Today, the UK & Ireland forms a critical and growing part of our Global network and is one of our core operating hubs alongside Cambridge, M.A., USA and Paris, France. As a UK & Ireland Hub we are collaborating to deliver outcomes for patients, health services and our community of current and future colleagues.​​ Three of Ipsen’s leading medicines are manufactured in the UK & Ireland, with our UK footprint also ‘home’ to the global neuroscience franchise, with neurotoxin research, development, and manufacturing capabilities located across our Milton Park (Oxford) and Wrexham facilities.